May 28, Minister of Health of Panama Dr. Miguel Mayo visited the production plant in SPbSRIVS. Director of Institute Dr. Viktor Trukhin conducted the excursion for the guest on the influenza vaccine production. During the official visit Dr. Miguel Mayo was acquainted with both the current activities of the Institute and perspective plans. In particular,
The first shipment to Latin America of the Russian vaccine against yellow fever was the result of joint efforts by the St. Petersburg Research Institute of Vaccines and Serums (SPbSRIVS) of the Russian Federal Biomedical Agency and the Chumakov Federal Research Center for Research and Development of Immunobiological Preparations at the Russian Academy of Sciences.
technical committee
Another meeting of the technical committee dedicated to the cooperation between Russia and Nicaragua as part of the vaccine technology transfer project was held. The meeting was attended by Mr. Victor Trukhin, Director of SPbSRIVS, and Mr. Stanislav Uiba, CEO at Mechnikov S.A.
Tagged under: ,
As part of the official visit to Venezuela of the Russian Deputy Prime Minister for Defense Industry Mr. Dmitry Rogozin, the Director of SPbSRIVS of the Russian Federal Biomedical Agency Mr. Victor Trukhin and the Minister of Health of Venezuela Ms. Luisana Melo signed a memo of understanding providing for an assessment of the cooperation
Tagged under: ,
On October 22, 2016 Managua, the capital of Nicaragua, hosted an official event celebrating the construction completion of Latin America’s first immunobiological vaccine factory – Mechnikov. The ceremony was attended by the Minister of Health of Russia Ms. V.I. Skvortsova, Head of FMBA of Russia Mr. V.V. Uiba, PAHO/WHO Director Ms. Carissa F. Etienne, Director

Vaccine factory (video of Channel 5)

September 30, 2016, a meeting of the co-chairs of the Intergovernmental Russian-Nicaraguan Commission on Trade, Economic, Scientific, and Technology Cooperation was held in Moscow. Deputy Director of SPbSRIVS, Mr. Andrey Vasiliev, presented a new project envisaging a new pharmaceutical facility in Managua, Nicaragua, to synthesize influenza vaccines using an imported Russian active component, under development
In Managua, engineers of the joint Russian-Nicaraguan vaccine company Mechnikov S.A. began the installation of the cleanroom facility. All necessary materials were flown to the capital of Nicaragua on cargo flights from St. Petersburg. “Almost 100 tons of equipment and materials for the various cleanrooms were shipped to Managua by air freight. Although this was